It must be noted that this is an acute increase in KRAS expression, which might have very different effects than KRAS overexpression caused by gene amplification that has been associated with resistance to EGFR and KRAS targeted therapies in colorectal cancer cell lines [72]. The gene discussed is EGFR; the disease is colorectal cancer.